Suboxone Lawsuit Payout Per Person 2026: What’s Actually Confirmed
Quick Answer
- The Suboxone tooth decay case is a federal MDL, not a class action; each plaintiff pursues an individual claim, not a shared payout.
- No settlement fund exists yet, so any “$50,000 to $150,000” figure you’ve seen online is an unverified attorney estimate, not a confirmed payout.
- There’s no MDL-wide claim deadline because there’s no settlement; your filing window depends on your state’s individual statute of limitations.
If you’re searching “suboxone lawsuit payout per person,” here’s the direct answer: no one can tell you a confirmed number yet, because no settlement has been reached. Every dollar figure circulating online right now is a law firm’s projection, not a court-approved payout.
That matters if you’re trying to plan around this financially. As of June 2026, roughly 1,833 cases were pending in the federal Suboxone MDL, and by August 2026 that count sat around 1,827, according to case tracking from Drugwatch. The first bellwether trial isn’t scheduled until March 2028.
This article separates what’s actually confirmed in court records from what’s speculation dressed up as certainty. One detail that surprises people: this isn’t technically a “class action” at all, even though that phrase shows up constantly in search results.
The Facts
| Category | Detail |
|---|---|
| Case | In re: Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation, MDL No. 3092 |
| Court | U.S. District Court for the Northern District of Ohio |
| Judge | J. Philip Calabrese; Magistrate Judge Jennifer Dowdell Armstrong |
| Status | Pretrial discovery and bellwether case selection; no settlement, no trial dates |
| Fund Size | Not yet confirmed, no settlement announced |
| Est. Per Person | Not yet determined; attorney projections range widely and are unconfirmed |
| Claim Deadline | Varies by state statute of limitations; no MDL-wide deadline exists |
| Administrator | Not yet appointed |
| Proof Needed | Documented Suboxone film use and dental injury records to support a filed lawsuit |
Is the Suboxone Lawsuit Real, or Is This a Scam?
The Suboxone litigation is real, verified in federal court records under MDL No. 3092 in the Northern District of Ohio. It is not a scam, but it’s also not a settlement you can currently collect from.
Roughly 1,827 individual lawsuits were pending in the federal court system as of August 2026. Some attorneys estimate the broader total, including cases filed in state courts, at close to 18,000 nationwide.
Here’s the catch: none of that means money is available right now. No settlement has been announced, and no trial has produced a verdict. If a message promises you a Suboxone “payout” today, it’s describing a projection, not an actual payment.
Key Takeaway: The Suboxone case is a legitimate, court-verified mass tort, but zero dollars have been confirmed or distributed to any claimant as of this writing.
How Much Is the Suboxone Lawsuit Payout Per Person?
There is no confirmed per-person payout because no settlement or bellwether verdict has occurred yet. Every number you’ve seen is a law firm’s estimate based on comparable pharmaceutical cases, not a court-approved figure.
Attorney projections vary widely across firms, which itself is a signal these are guesses, not facts.
| Source | Projected Range | Status |
|---|---|---|
| Drugwatch (Aug 2026) | $10,000 to $150,000, some estimates to $500,000 | Explicitly labeled speculative |
| TorHoerman Law | $25,000 to $150,000+ | Projection, no settlement reached |
| King Law | $50,000 to $150,000+ | Firm’s internal tier estimate |
| Lawsuit Information Center | $50,000 to $150,000 (settlement); over $1 million (trial verdict, speculative) | Explicitly called premature |
Not yet determined. No fund has been established because there’s no global settlement and no jury verdict to set a benchmark. Any specific number quoted to you individually should be treated as a projection until an actual settlement or verdict exists.
What Factors Would Affect Your Suboxone Payout If a Settlement Happens?
If a settlement or verdict eventually occurs, individual payout amounts would likely depend on the severity of your dental injury and the strength of your documentation. This is standard for mass tort litigation, not unique to Suboxone.
Factors attorneys commonly cite as relevant include:
- Severity of dental damage (cavities versus full tooth loss versus multiple extractions)
- Total cost of dental treatment, including root canals, crowns, or implants
- Duration of Suboxone film use before the injury developed
- Whether you had documented prior dental health before starting treatment
- Any health insurance liens that could reduce your net payout
None of these factors currently connect to a real dollar figure, since no tiered settlement structure has been approved by any court.
How to File a Suboxone Lawsuit in 2026
Filing a Suboxone lawsuit means bringing an individual claim into the MDL process, not submitting a claim form to a settlement fund. Here’s the general process being used by plaintiffs currently in the litigation.
- Gather proof you were prescribed and used Suboxone sublingual film, not just any buprenorphine product.
- Collect dental records documenting tooth decay, extractions, or related treatment.
- Confirm your state’s statute of limitations hasn’t already expired for your claim.
- Consult an attorney to evaluate whether your case fits the current MDL criteria.
- File your complaint, which typically gets transferred into MDL No. 3092 in Ohio.
- Respond to any court-ordered record requests tied to discovery.
- Wait through pretrial discovery; your case won’t go to trial unless selected as a bellwether or the MDL resolves globally.
Filing itself doesn’t cost you anything upfront in a standard contingency arrangement, but you should confirm fee structures directly with any attorney before signing.
What Proof Do You Need for a Suboxone Tooth Decay Claim?
You need documentation linking your Suboxone film use directly to a diagnosed dental injury. Courts and attorneys both rely heavily on this evidence to evaluate claims.
- Pharmacy or prescription records showing Suboxone sublingual film use, not tablets or another form
- Dental records showing diagnosis of decay, cavities, infection, or tooth loss
- Treatment records for procedures like root canals, extractions, or implants
- Timeline showing when treatment began relative to when dental problems appeared
- Any prior dental records establishing your baseline oral health before treatment
Key Takeaway: Documentation quality, not the size of the MDL, is what attorneys say determines whether an individual claim moves forward successfully.
Suboxone Lawsuit Filing Deadline: Is There a Claim Deadline in 2026?
There is no single nationwide filing deadline because no settlement exists to attach one to. Instead, each plaintiff is bound by their individual state’s statute of limitations.
Many states set a general personal injury filing window, and several sources note a June 2025 cutoff already passed for a number of states under standard timelines. Some plaintiffs may still qualify under a tolling agreement reported as early as July 2024, which can extend filing eligibility in specific circumstances despite a standard 2-year limitations period.
Reality Check: No legitimate settlement claim process for Suboxone exists yet, so anyone asking you to pay an upfront fee to “register” for a payout is not describing a real, court-approved process. Filing an actual lawsuit through an attorney on contingency is the only verified path currently available.
Is the Suboxone Lawsuit a Class Action?
No, the Suboxone tooth decay litigation is a multidistrict litigation, not a class action, despite that phrase showing up constantly in search results. This distinction directly affects how any future payout would work.
In a class action, one settlement fund gets divided among a group under one agreement. In an MDL, cases are consolidated only for shared pretrial work, like discovery and expert testimony. Each plaintiff keeps an individual claim and would receive an individual settlement or verdict amount if the case resolves.
That means there is no single “per person” number that applies to everyone equally, even after a resolution. Your payout, if any, would depend on your specific injury and evidence, not an even split of one fund.
What Is the Suboxone Lawsuit About?
The Suboxone lawsuits allege that Indivior Inc., the drug’s manufacturer, failed to adequately warn patients and doctors that its sublingual film formulation could cause severe dental damage. Plaintiffs claim years passed between early reports and the eventual FDA warning.
Suboxone film, placed under the tongue to treat opioid use disorder, is acidic by design. Plaintiffs allege prolonged oral exposure to the dissolving film caused tooth decay, cavities, infections, and tooth loss, sometimes in patients with no prior dental problems.
The FDA issued a Drug Safety Communication on January 12, 2022, warning that dental problems had been reported with buprenorphine medicines dissolved in the mouth. The agency’s review identified 305 dental adverse event cases, with 131 classified as serious.
Key Takeaway: The core legal claim is failure to warn, not that the drug doesn’t work; the FDA has repeatedly stated buprenorphine’s addiction-treatment benefits outweigh the dental risk when patients are properly warned.
Who Is Named as a Defendant in the Suboxone Lawsuits?
The primary defendant is Indivior Inc., the manufacturer of Suboxone sublingual film. Additional companies have been named depending on the specific complaint.
Court filings referenced in early cases also name Aquestive Therapeutics, MonoSol Rx, Inc., and Reckitt Benckiser LLC, tied to different roles in developing, manufacturing, or previously marketing the product. Indivior was spun off from Reckitt Benckiser in 2014 and has been the central defendant in most filings since.
What’s the Current Status of the Suboxone MDL in 2026?
As of August 2026, the Suboxone MDL remains in pretrial discovery, with no settlement reached and no trial dates confirmed. The litigation is progressing through a structured bellwether selection process rather than moving toward immediate resolution.
Key confirmed developments:
- February 2024: The Judicial Panel on Multidistrict Litigation consolidated the cases into MDL No. 3092.
- December 31, 2024: Judge Calabrese largely denied Indivior’s motion to dismiss, allowing failure-to-warn and design defect claims to proceed.
- February 25, 2026: Judge Calabrese randomly selected 100 plaintiffs for the Core Discovery Pool, a step toward eventual bellwether trial selection.
- August 2026: Roughly 1,827 cases remain pending in the federal MDL; no settlements or trial dates have been publicly announced.
When Will the First Suboxone Bellwether Trial Happen?
The first bellwether trial in the Suboxone MDL is not expected until March 2028, according to litigation tracking published in May 2026. This is a significantly longer timeline than many early projections suggested.
Bellwether trials work as test cases. The court narrows a large pool of plaintiffs down through several rounds, from an initial group into a smaller discovery pool, and eventually to a handful of cases that go to trial first. Outcomes from those trials typically shape settlement negotiations for the remaining thousands of cases.
- Initial pool: hundreds of plaintiffs reviewed for records
- Core Discovery Pool: 100 plaintiffs selected February 25, 2026
- Narrowed trial candidates: expected to shrink further through 2027
- First bellwether trial: expected March 2028
Key Takeaway: Anyone telling you a Suboxone settlement is imminent in 2026 or 2027 isn’t reflecting the court’s own published bellwether timeline, which points to 2028 at the earliest for the first trial verdict.
Is There a Separate Suboxone Antitrust Settlement?
Yes, and it’s a completely different case from the tooth decay litigation, which is a common point of confusion. An antitrust settlement involving Suboxone has already resolved, but it has nothing to do with dental injury claims.
That earlier case involved direct purchasers of the drug alleging Indivior and Reckitt Benckiser illegally limited competition, causing consumers to overpay. It settled separately and does not provide compensation for tooth decay or dental damage. If you’re researching a payout for dental injuries, that resolved antitrust case does not apply to your claim.
What Happens Next
February 25, 2026 (completed): Judge Calabrese selected 100 plaintiffs for the Core Discovery Pool.
Through 2027 (expected): Discovery continues on the Core Discovery Pool, with further narrowing toward final bellwether trial candidates.
Expected March 2028: First bellwether trial scheduled to begin, based on current court timelines.
Expected post-2028: Settlement negotiations for the broader MDL would likely follow bellwether trial outcomes, though no formal timeline has been confirmed.
Frequently Asked Questions
How much will I get from the Suboxone lawsuit?
No confirmed amount exists because no settlement or bellwether verdict has occurred yet.
Attorney projections range widely, from around $10,000 to $200,000 or more, but these are estimates, not facts.
Your eventual payout, if any, would depend on your individual injury severity and documentation.
Is the Suboxone lawsuit a class action?
No, it’s a multidistrict litigation (MDL No. 3092), which consolidates individual claims for pretrial purposes only.
Each plaintiff keeps a separate claim rather than sharing one settlement fund equally.
This is different from a class action where one agreement covers the whole group.
When will Suboxone lawsuit settlements start paying out?
No settlement exists yet, and the first bellwether trial isn’t expected until March 2028.
Settlement talks for the broader case would likely follow bellwether trial outcomes.
Treat any current “payout date” claims as speculation.
What is the deadline to file a Suboxone lawsuit?
There’s no single MDL-wide deadline because there’s no settlement fund to attach one to.
Your deadline depends on your individual state’s statute of limitations.
Some plaintiffs may qualify under a tolling agreement; consult an attorney to check your specific state’s rules.
Who can file a Suboxone tooth decay lawsuit?
Generally, people who used Suboxone sublingual film and developed documented dental injuries, such as decay, infections, or tooth loss.
You’ll need pharmacy records and dental treatment records connecting the two.
Eligibility also depends on your state’s filing deadline not having already passed.
Did the FDA confirm Suboxone causes tooth decay?
The FDA issued a Drug Safety Communication on January 12, 2022, warning of reported dental problems with buprenorphine dissolved in the mouth.
The agency identified 305 dental adverse event cases, with 131 classified as serious.
The FDA has stated the drug’s addiction-treatment benefits still outweigh this risk when patients are properly warned.
How many Suboxone lawsuits have been filed?
Roughly 1,827 cases were pending in the federal MDL as of August 2026.
Some attorneys estimate the total nationwide, including state court filings, at close to 18,000.
The case count has grown steadily since consolidation began in February 2024.
Check the official MDL docket or speak with an attorney directly before relying on any specific dollar estimate you’ve seen online. The most important fact to hold onto: no Suboxone tooth decay settlement has been reached as of August 31, 2026, and the first bellwether trial isn’t expected until March 2028.
